SanguiBioTech GmbH
SanguiBioTech GmbH, a pioneering biotechnology firm headquartered in Germany, focuses on innovative solutions in the fields of regenerative medicine and advanced wound care. Founded in 2006, the company has established itself as a leader in developing unique therapeutic products that harness the power of blood-derived biomaterials. With a strong presence in Europe and expanding operations globally, SanguiBioTech is renowned for its flagship product, the SANGUINATE® system, which offers a novel approach to tissue regeneration. This cutting-edge technology distinguishes itself through its ability to enhance healing processes, making it a vital asset in both clinical and surgical settings. SanguiBioTech's commitment to research and development has positioned it as a key player in the biotechnology industry, with notable achievements in product innovation and regulatory approvals, further solidifying its reputation for excellence in healthcare solutions.
DitchCarbon Score
How does SanguiBioTech GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
SanguiBioTech GmbH's score of 0 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
SanguiBioTech GmbH's reported carbon emissions
SanguiBioTech GmbH, headquartered in Germany, currently does not have available carbon emissions data for recent years, as no specific figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined by the company. This absence of data suggests that SanguiBioTech may still be in the early stages of formalising its climate commitments or reporting its emissions. In the context of the biotechnology industry, companies are increasingly expected to establish clear sustainability goals and transparent reporting practices to address climate change effectively.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
SanguiBioTech GmbH is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
